ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,205Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 1006

$652K Total Retail Price of All Prescriptions

Rank: 128 out of 1006

392 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,257 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 378 334 1 3
LEVOTHYROXINE SODIUM 372 360 2 2
METOPROLOL TARTRATE 324 312 3 7
AMLODIPINE BESYLATE 323 293 4 4
FUROSEMIDE 302 284 5 6
SIMVASTATIN 290 285 6 1
OMEPRAZOLE 212 195 7 9
METFORMIN HCL 211 199 8 10
ATORVASTATIN CALCIUM 190 175 9 5
ATENOLOL 163 126 10 13
ZOLPIDEM TARTRATE 161 149 11 14
NEXIUM 157 101 12 28
POTASSIUM CHLORIDE 135 118 13 30
DONEPEZIL HCL 130 130 14 17
SERTRALINE HCL 121 89 15 19
HYDROCHLOROTHIAZIDE 117 91 16 11
WARFARIN SODIUM 111 111 17 8
ADVAIR DISKUS 110 110 18 37
METOPROLOL SUCCINATE 106 105 19 12
TRAMADOL HCL 103 92 20 35
CITALOPRAM HBR 103 100 20 24
DOXAZOSIN MESYLATE 99 99 22 87
TRIAMTERENE-HCTZ 97 93 23 58
ALLOPURINOL 94 89 24 31
HYDROCODONE-ACETAMINOPHEN 93 87 S3 25 25
ESCITALOPRAM OXALATE 92 83 26 27
KLOR-CON M10 90 85 27 216
AZITHROMYCIN 89 79 28 39
TAMSULOSIN HCL 88 88 29 23
SYNTHROID 88 76 29 42
PANTOPRAZOLE SODIUM 86 86 31 32
ISOSORBIDE MONONITRATE ER 81 81 32 59
BISOPROLOL-HYDROCHLOROTHIAZIDE 77 77 33 202
CRESTOR 77 66 33 18
GABAPENTIN 75 65 35 20
CLOPIDOGREL 72 71 36 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 70 37 38
PRAVASTATIN SODIUM 69 57 38 15
MIRTAZAPINE 66 63 39 26
QUETIAPINE FUMARATE 66 61 39 45
CARBIDOPA-LEVODOPA 65 65 41 80
NAMENDA 65 65 41 34
LACTULOSE 62 62 43 104
DIOVAN 62 62 43 16
NITROFURANTOIN 61 61 45 205
RISPERIDONE 60 54 46 40
FLUTICASONE PROPIONATE 59 45 47 55
ALENDRONATE SODIUM 58 58 48 29
KLOR-CON M20 56 56 49 70
VYTORIN 55 42 50 145
PREDNISONE 55 55 50 33
AMIODARONE HCL 54 54 52 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.